Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02718066
What this trial is testing

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

Who this might be right for
MelanomaRenal Cell CarcinomaNon-Small Cell Lung Cancer
HUYABIO International, LLC. 96
Testing effectiveness (Phase 2)UnknownNCT02919371
What this trial is testing

Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)

Who this might be right for
Renal Cell Carcinoma
King Faisal Specialist Hospital & Research Center 77
Testing effectiveness (Phase 2)UnknownNCT00184015
What this trial is testing

Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)

Who this might be right for
Renal Cell Cancer
University of Southern California 50
Early research (Phase 1)Ended earlyNCT00492440
What this trial is testing

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Cytheris SA 9
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)Study completedNCT01835158
What this trial is testing

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 157
Large-scale testing (Phase 3)Active Not RecruitingNCT04195750
What this trial is testing

Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 755
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741617
What this trial is testing

A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma

Who this might be right for
Urologic Neoplasms
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Testing effectiveness (Phase 2)Study completedNCT00039429
What this trial is testing

Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group 180
Early research (Phase 1)Study completedNCT01625936
What this trial is testing

CRLX101 Plus Bevacizumab in Advanced RCC

Who this might be right for
Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 22
Early research (Phase 1)Ended earlyNCT00091611
What this trial is testing

Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
National Cancer Institute (NCI) 3
Very early researchActive Not RecruitingNCT06318871
What this trial is testing

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Who this might be right for
Renal CarcinomaRenal Cell CarcinomaUrothelial Carcinoma+2 more
Dana-Farber Cancer Institute 5
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07840001
What this trial is testing

Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Locally Advanced Clear Cell Renal Cell Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Testing effectiveness (Phase 2)Study completedNCT00056173
What this trial is testing

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellMetastases, Neoplasm
Aptose Biosciences Inc. 43
Very early researchStudy completedNCT02729194
What this trial is testing

Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
University of Michigan Rogel Cancer Center 16
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Testing effectiveness (Phase 2)Looking for participantsNCT07172802
What this trial is testing

GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer (NSCLC)+3 more
GI Innovation, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT04118855
What this trial is testing

Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Neoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell Carcinoma
RenJi Hospital 20
Very early researchUnknownNCT05961111
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Who this might be right for
SarcomaCarcinomaDigestive Cancer+7 more
Shanghai Yunying Medical Technology 20
Next Page